A B S T R A C T Lymphocytes binding
INTRODUCTION C-reactive protein (CRP)l constitutes a material which exists in low concentrations in normal serum but which is often elevated during the course of acute inflammatory reactions such as infection, trauma, or acute rheumatic fever (1) (2) (3) (4) (5) (6) . Recent comparative analysis of amino acid sequences as well as electron microscopic structure suggest that CRP may share evolutionary sources with Clt related to the Clq component of complement (7) . Previous reports by Mortensen et al. (8) (9) (10) have indicated that CRP may bind to lymphocytes and in particular, may actually adhere to T cells activated by antigens but not by mitogens such as phytohemagglutinin. Our previous studies have indicated a marked increase in proportions of "active" rosette-forming T cells among children with acute rheumatic fever (11) . It was not clear whether active (or rapid) rosette-forming cells constituted a population of immunologically activated T cells that somehow increased during the acute rheumatic process. Recent reports have related increments in proportions of active T-cell rosettes related to delayed type hypersensitivity reactions after in vivo skin testing (12) . Previous studies had appeared to indicate that proportions or numbers of active rosettes might correlate with immune competence (13, 14) . The purpose of the present study was to examine lymphocyte subpopulations in acute rheumatic fever patients with particular attention to what distinct populations of lymphocytes showed CRP binding. It was felt that such cells might represent immunologically committed or possibly antigen-activated cells called forth in the host response to the disease process.
METHODS
Patients studied. 31 patients with acute rheumatic fever were studied during the first 3 wk of April 1977. All of the patients were hospitalized at the Free Rheumatic Heart Center in Cairo, Egypt (11, 15) , and were between the ages of 3 and 14 with active acute rheumatic fever. The diagnosis was established using the modified Jones Criteria as suggested by the American Heart Association (16) . The majority of patients studied were subjects in the relatively acute stages of rheumatic pancarditis, 1-8 wk after the onset of symptoms. Of these patients, 11 were experiencing their first attack, whereas the other 20 children were studied in an exacerbation having had two to seven previous episodes of carditis or active chorea. 10 patients with acute chorea and associated carditis, or evidence on physical examination of active mitral valve involvement were included in the study; the remainder were studied during the progress of active carditis.
9 of the 21 patients with active carditis had received corticosteroids as therapy for their flagrant carditis. Concurrent dosage of prednisone ranged from 5 to 30 mg/day. Nine patients with active carditis were also studied who were receiving salicylates alone, and three were studied before the administration of any therapy. The 10 patients with chorea were receiving salicylates as well as reserpine preparations and phenobarbital for the control of their movement disorder.
The average age of patients with carditis was 9.1 years (13 females and 8 males). The chorea patients averaged 10.3 years of age (8 females and 2 males).
Six normal control subjects were studied from control Egyptian children hospitalized at Cairo University Hospital on the general pediatric service for correction of congenital deformities or treatment of noninflammatory conditions. In addition, a group of'24 normal children, ages 5-15 and matched for age and sex, were studied in Egypt and AlbuquerqIue.
Special studies. CRP was determined in serum samples using radial diffusion and the techni(lue of Kindmark (17) , and all results expressed as nanograms per deciliter of' serum. Serum samples which could not be used f'or CRP determination because of the limits of sensitivity of' the radial diffusion method were assayed using the radioimmunoassav modified slightly from the original techni(lue described by Claus et al. (6) . In this assay, highly purified CRP was labeled with 1311 using the Bolton-Hunter reagent. Labeled CRP was repurified after labeling by elution from C-polysaccharide columns to insure specificity and biologic reactivity. The range of values for normal serum (50 samples) was similar to that previously recorded (60-8,000 ng/dl) (6) . Serum samples assayed in parallel by the modified radial dif'fusion assay and radioimmunoassay, generally showed good agreement with not more than a 15% diff'erence when the two methods were run in parallel on the same samples.
Lymphocytes were isolated from 12-ml samples of' heparinized blood using Ficoll-Hypa(que and gradient separation (18) . After harvesting the lymphocytes f'rom the gradient, mononuclear cells were depleted of adherent cells and monocytes using adherence to glass petri dishes at 37°C for 30 min (19) . This 37°C incubation also served to allow shedding of adherent immunoglobulin, thus depleting cell surfhaces of the latter as noted by Horwitz et al. (20) . Nonadherent cells were then utilized f'or assay of CRP binding. In preliminary assays, whole mononuclear cell preparations in which adherent cells had not been depleted and adherent cells, recovered from petri dishes by gentle scraping wvith rubber policeman were studied, to ascertain whether such cells constituted a major fraction showing CRP binding. (22) , anti-CRP antiserum was tested for possible anti-P specificity tusing P coimiponent affixed to Sepharose 4B beads (Pharmacia Fine Chemlicals Inc., Uppsala, Sweden) in the presence of'calciumil ionls (23) . Sepharose 4B beads coated with P componient were strongly positive with specific anti-P-component antiserumil but negative with our anti-CRP antisera. These experiments ruled out inadvertent specificity for P componient in the antisera used. All anti-CRP antisera used in the cell-suirf'ace marker studies showed complete absorption of activity in the systems studied using CRP isolated from capsular (Cs) polysaccharide columns (8) and f'reed of contaminants by subsequent gel filtration. IgG fractions from rabbit anti-CRP antiserum were digested by pepsin as previously described (21) to obtain F(ab')2 fragments and were then labeled with either fluorescein or rhodamine. Such labeled F(ab')2 preparations showed F/P ratios ranging between 1.5 and 2.0. Completeness of pepsin digestioni was assayed using inhibition of precipitation between rabbit Fc and specific goat antirabbit Fc antiserum in agar gel and by acrylamide gel electrophoresis. In several instances, pepsin-digested material was also absorbed with whole Cowan I protein A-containing Staphyloccus aureus to insure removal of whole IgG or material containing Fc determinants. Mononuclear cell preparations were incubated with fluoreseein-labeled F(ab')2 of anti-CRP and, after washing and resuspension, examined under the Zeiss fluorescence microscope using epifluoreseence, a mercury HBO 200 W lamp with BG12 primary filter, 53 Barrier filter, and the fluorescein isothiocynate filter (Carl Zeiss, Inc., New York). Double labeling for CRP and other cell surface markers employed fluoreseein-labeled aggregates of' IgG to detect Fe receptors (11, 24) in con-junction wvith rhodaminelabeled F(ab')2 fragments of' anti-CRP. In addition, erythrocyte antibody (EA) rosettes prepared from bovine cells coated with optimal sensitizing dilution of isolated rabbit anti-bovine IgG were also used for the detection of Fe receptor-bearing cells (25) . IgG, coating bovine erythrocytes, was titered to provide a plateau of optimnal dilution for producing reproducible Fc receptor rosettes. Preliminary studies wvere conducted to determine whether cells binding fluoreseeinlabeled aggregates wvere idenitical to those bearing Fc receptors as detected by the IgG sensitized ox-cell techni(lue.
Comparative data illustrating these findings are presenited in Table I 50 Al of' standard l)acterial stispenision was added, the volume was brought to 2.5 ml, and( the mixtuire was then centrif'uged at 1,000 g to remove nonia(dlherenit bacteria. Lymphocyte stispenisionis were genttly distributed on C-Reactive Proteini-Bitndinig Lymphocytes Before use in the respective assays, anti-CRP antiserum as well as normal rabbit sera were absorbed with lymphocytes using 10 x 106 cells per ml of serum. Background controls with normal rabbit serum or bacteria and cells alone never showed >1% apparent binding.
Specificity for both the indirect immunofluorescence as well as S. aureus protein A methods was tested by absorption of anti-CRP antisera with highly purified preparations of human CRP prepared from pneumococcal C-polysaccharide immunoabsorbent columns and CRP-rich pleural or ascitic fluids as previously described by Mortensen et al. (8) .
Cell subpopulation separation. Cells depleted of monocytes or adherent cells were passed over Ig-anti-IgG Degalan columns to further deplete cells of those bearing surface Ig (19, 21) . Cells were studied for CRP binding before and after such column passage.
In addition, the technique of Moretta et al. (27, 28) was utilized in an attempt specifically to prepare T cells bearing Fc receptors for IgM as well as those with receptors for Fc of IgG. This technique utilized enrichment for T-cell rosetting cells with neuraminidase-treated sheep erythrocytes followed by overnight incubation in 5% CO2 air at 37°C in Hanks' balanced salt solution. Cells undergoing this selective T-cell enrichment and overnight shedding were then examined for T cells bearing IgM (T,u) and IgG receptors (Ty) as well as for presence of CRP using direct immunofluorescence and F(ab)2 anti-CRP in conjunction with bovine cell rosettes coated with rabbit IgM or IgG. These experiments also served to provide some evidence as to stability of surface binding to CRP.
Attempts were made to determine if active T-cell rosetting cells contained a population capable of binding CRP. In these experiments, active rosettes were prepared as previously described (11), and after rosetting at 1 h, actively rosetting cells were separated on Ficoll-Hypaque and adherent erythrocytes were lysed using 0.83% ammonium chloride for 10 min at 37°C. Cells sedimenting to the bottom of the gradient and, therefore, lymphocytes making active or rapid rosettes, were studied immediately or, in some instances, incubated overnight at 37°C in 5% CO2 air in 20% fetal calf serum -Eagle's minimum essential medium, and then stained by direct immunofluorescence using F(ab')2 fragments of anti-CRP. In parallel, the lymphocytes not forming active rosettes were processed and subsequently examined for immunofluorescent CRP binding.
A final control involved studies of five patients with chronic myelogenous leukemia and eight patients with acute lymphocytic leukemia. Small proportions (1-5%) of CRP-binding cells in peripheral blood samples from some of these subjects were always associated with T lymphocytes as monitored by concomitant E rosetting. No binding of CRP was detected with immature granulocytes or blast cells from patients with various forms of leukemia.
RESULTS'
A marked increment in both proportions and total numbers of CRP-binding cells was noted in peripheral blood lymphocytes obtained from patients with acute rheumatic fever when compared with values obtained using normal child controls. These data are presented in Table II . Values for proportions of cells bearing CRP were slightly higher using direct immunofluores- (31, 32) . Accordingly, a series of experiments which focused on specific T-cell populations were conducted. T cells bearing specific IgM or IgG Fc receptors were prepared by the techniques of Moretta et al. (27, 28) . Results of T,t-and Ty-cell determinations on children with acute rheumatic fever as well as normal controls are given in Table VI . It was clear that T,u cells predominated and that Ty cells constituted only a small fraction of the total T cells that were specifically enriched by neuraminidase sheep cell rosetting and overnight incubation to allow shedding and membrane stabilization. Of interest were the findings of significant elevation of proportions and numbers of Ty cells in rheumatic children with decrease in proportions of T,u cells as compared to controls. After isolation of T cells using rosetting with neuraminidasetreated sheep erythrocytes and overnight incubation at 37°C in IgM-free medium, concurrent labeling of T,u and Ty cells was performed using fluoresceinlabeled F(ab')2 fragments of anti-CRP. These parallellabeling experiments showed that no T,u cells bearing receptors for Fc of IgM showed CRP binding, whereas 25-60% (mean 46%) of Ty cells bearing IgG Fc receptors bound CRP. Thus, when specific T-cell populations were examined for CRP, only Ty cells showed surface staining. Representative data illustrating these findings are given in Table VII .
Experiments were also conducted on cells remaining at the Ficoll-Hypaque gradient interface after neuraminidase-rosetting of E-binding T cells. In five experiments, 12-16% of cells remaining in this B-cell layer showed CRP binding-even after overnight incubation at 37°C. Cell surface-marker studies in this presumptive B-cell layer showed 50-65% cells with surface Ig and 20-26% cells with Fc receptors by bovine EA rosettes. In two experiments where enough cells were present for accurate double-labeling studies on these isolated B cells after overnight incubation, 40 and 38% showed concurrent binding of pepsin-digested fluorescein-labeled anti-F(ab')2 and rhodaminelabeled F(ab')2 of anti-CRP. This clearly established that there was a definite overlap between cells bearing * Unfractionated cells and isolated T cells studied by indirect immunofluorescence using F(ab')2 anti-CRP.
C-Reactive Protein-Binding Lymphocytes surface Ig and those capable of binding CRP. In addition, double-labeling experiments using EA rosettes and anti-CRP F(ab')2 showed concomitant occurrence of these surface markers in 40 and 52% of isolated Bcell fractions. T-cell contamination as monitored by E rosettes was <2%. These data are given in Table  VIII . Experiments were next designed to examine whether active rosette-forming cells participated in CRP binding. Very little overlap in these two populations oc- 
DISCUSSION
The current findings indicate that a marked increase in cells binding CRP occurs during the course of' acute rheumatic fever. This was demonstrated using two, parallel independent methods of' lymphocyte-CRP binding, which included direct immunofluorescent la- (38, 39) .
CRP elevation is known to accompany many acute or subacute inflammatory conditions (1-6, 40, 41) . The exact origin or sites of CRP synthesis as well as localization within inflammatory tissue previously have been studied by several groups (42) (43) (44) (45) (46) . It is wvell known that marked CRP elevation in serum accompanies the acute process in rheumatic fever (4) . No precise definition of the role of CRP in such disorders as acute rheumatic fever has yet been identified. Because of' its elevation in so many inflammnatory reactions, CRP has long been regarded merely as an actutephase reactant similar perhaps to other serumii proteiiis of' this type such as ceruloplasmin, haptoglobin, or seromucoid (41, 47, 48) . It is clear that CRP is present in small amounts in normal human serumil (6) (49, 50) . In the presenit study, proportions of'T,i cells have been noted to be decreased during the acute rheumilatic process, whereas Ty cells were significantly inierease(l. However, T cells binding CRP clearly appeared also to have IgG Fe receptors. WVhether such Ty cells carry a specific functionial role such as suppressor or killer fuinction remains to be determined. Recent data presented by Moretta et al. (50) appear to indicate a suppressor role for Ty cells in some in vitro assay systems involving B-cell activation.
Our studies of' CRP in supernates from lymphocyte cultures or merely incuibation experiments have not provided clear evidence for active synthesis of' CRP by isolated T cells. These possibilities have been recently pursued in view of the report of' extensive sequence homologies between Cl and CRP and the Pamyloid component (7) . It is important in this regard to point out that F(ab'), fragments obtained from anti-CRP antiserum generously provided by Dr. E. Gotschlich showed similar reactivities in the lymphocyte cell surface assays to those obtained from Dr. Osmand and Dr. Gewurz. The antiserum provided by Dr. Gotschlich was prepared against crystallized CRP whereas that obtained from Dr. Ossmand and Dr. Gewurz was prepared from affinity column-purified material. Our testing for anti-P-component specificity in anti-CRP antisera proved negative (22, 23) . If lymphocytes were under certain circumstances capable of CRP synthesis, they might under previous or current evolutionary circumstances be capable of CI synthe-sis as well. However, the vast bulk of evidence clearly implicates the liver as primary site of synthesis for CRP (42, 46) .
Recent extensive studies (51) (52) (53) (54) (55) (56) (57) have described many of the important potential biological effects of CRP both in vitro and in vivo. Previous work has indicated that mixed leukocyte reactions are diminished when non-HLA-compatible lymphocytes from two patients with acute rheumatic fever are studied together in one-way stimulation (58) . Gewurz et al. (8, 53) have also shown that mixed leukocyte reaction in normal subjects is diminished by CRP. In the latter instance, CRP effect was attributed to modulation of antigenactivated cells in the mixed leukocyte reaction. It now seems important to recognize that proportions of CRPbinding cells may directly influence several expressions of the immune response. These collective findings are of particular interest in the light of current reports indicating that streptococcal antigens produce an altered cell-mediated immune response in patients with acute rheumatic fever (59) .
